4th Annual RNA-Targeted Drug Discovery Summit - Digital Event - EST
Evvnt Promotion / evvnt
07.12.2021 - 09.12.2021 Online
Time: 8:30 am - 5:00 pm
Temi della conferenza
As the first small-molecule drug targeting RNA gains momentum, the ability to design small molecules capable of interacting with and modulating RNA is opening as a new avenue to target challenging disease pathways that have previously been considered undruggable.
As the first small-molecule drug targeting RNA gains momentum, the ability to design small molecules capable of interacting with and modulating RNA is opening as a new avenue to target challenging disease pathways that have previously been considered undruggable.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/851095-3?pid=4832
Speakers: Hashim Al-Hashimi, Professor, Duke University, Matthew Disney, Professor, Scripps Research, Jennifer Petter, Founder and Chief Innovation Officer, Arrakis Therapeutics and more
Brochure: https://go.evvnt.com/851095-3?pid=4832
Speakers: Hashim Al-Hashimi, Professor, Duke University, Matthew Disney, Professor, Scripps Research, Jennifer Petter, Founder and Chief Innovation Officer, Arrakis Therapeutics and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/851095-2?pid=4832
Ms. Katie Jacobs
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
